Cambridge Healthtech Institute’s 2nd Annual

Immunology and Oncology: Emerging Drug Targets and Therapeutics

New Drug Targets for Autoimmunity and Cancer

September 16-17, 2020


The rapid pace of research in the immunology field and medically relevant signaling pathways highlighted by new biologics on the market are providing a plethora of new drug targets, both intracellular and cell surface, whose modulation are showing promise for ameliorating diseases of the immune system or cancer. Often it’s the same target, modulated in opposite ways, that proves beneficial for both diseases. CHI’s Immunology and Oncology: Emerging Drug Targets and Therapeutics conference will cover these dual targets that are common to both: autoimmune and cancer indications. The conference will also focus on molecular targets in signaling pathways of immune cells whose modulation impacts either autoimmunity/inflammation or oncology. All drug modalities will be explored, though an emphasis will be on small molecules because many of the newest drug targets are intracellular molecules.


Who should attend: Scientists from Pharma and Biotech Companies and Academic Researchers from Departments such as: Immunology, Autoimmunity, Immuno-Oncology, Inflammation, Oncology, Cancer Drug Discovery, Immuno-Therapeutics.


Coverage will include, but is not limited to:                                        

  • Dual immuno/oncology targets: chemokine receptors, STING, ROR, and other innate immune system targets
  • Oncology-only targets: new checkpoint blockade targets (TIM3, LAG3, VISTA, TIGIT), Tumor-Associated Macrophages (TAMs), Tumor Microenvironment (TME) targets
  • Targeting cellular metabolism for immunology or cancer: arginase pathway, kyneurin pathway, and others


If you would like to submit a proposal to give a presentation at this meeting, please click here.


The deadline for priority consideration is February 26, 2020.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:

Anjani Shah, PhD

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-247-6252



For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286